Welcome back to the Ten Blocks podcast. This is Brian Anderson, the editor of City Journal.

Joining me on today's show

is Leor Sopier. He's been on the show before. He's a fellow at the Manhattan Institute, where he

researches pediatric gender medicine, education, cultural issues, and other concerns. He writes

frequently for CJ, analyzing the institutional capture of American

medical groups, and he's published for a number of other publications, Wall Street Journal,

Tablet, The Hill. He's testified before legislative health committees in several states.

Today, we're going to be discussing the Biden administration's

gender medicine policies and how they square with scientific evidence. So, Leor, really happy to

have you on the show again and looking forward to our discussion. Thanks for having me on, Brian.

So last month, the White House informed several media outlets that they opposed sex

trait modification procedures, which, as you've documented, include mastectomies, breast

implantation, facial reconstruction, genital surgeries, and more for children.

The stance that the White House adopted seemed contrary to the Biden administration's

longstanding support of these kind of procedures, and it certainly sparked a reaction

among those who support those procedures. You know,

one statement seemingly equated gender affirming care with mental health care, this particularly

in sense, transgender activists and advocacy groups. And, you know, the White House then rewarded it to indicate that pediatric

gender medicine represents, in its term, a continuum of care. Now, many people who don't follow

these issues are wondering, you know, what is going on here? What is all of this play with language?

So, you know, what is happening? What does the Biden

administration's mixed messaging reveal about its views on evidence-based medical policy in this

...